Literature DB >> 21566687

Hepatic Regeneration.

John Terblanche1, Thomas E Starzl.   

Abstract

Year:  1979        PMID： 21566687      PMCID： PMC3091032     

Source DB:  PubMed          Journal:  Viewp Dig Dis


× No keyword cloud information.
  7 in total

1.  Growth stimulation in the liver and tumour development following intraperitoneal injections of liver homogenates in the rat.

Authors:  K BLOMQVIST
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1957

2.  Liver regeneration in dogs: morphologic and chemical changes.

Authors:  A Francavilla; K A Porter; J Benichou; A F Jones; T E Starzl
Journal:  J Surg Res       Date:  1978-11       Impact factor: 2.192

3.  The effect of splanchnic viscera removal upon canine liver regeneration.

Authors:  T E Starzl; A Francavilla; K A Porter; J Benichou; A F Jones
Journal:  Surg Gynecol Obstet       Date:  1978-08

4.  Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver.

Authors:  D R LaBrecque; L A Pesch
Journal:  J Physiol       Date:  1975-06       Impact factor: 5.182

5.  Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs.

Authors:  T E Starzl; K Watanabe; K A Porter; C W Putnam
Journal:  Lancet       Date:  1976-04-17       Impact factor: 79.321

6.  A prospective controlled trial of sclerotherapy in the long term management of patients after esophageal variceal bleeding.

Authors:  J Terblanche; J M Northover; P Bornman; D Kahn; W Silber; G O Barbezat; S Sellars; J A Campbell; S J Saunders
Journal:  Surg Gynecol Obstet       Date:  1979-03

7.  Growth-stimulating factor in regenerating canine liver.

Authors:  T E Starzl; A F Jones; J Terblanche; S Usui; K A Porter; G Mazzoni
Journal:  Lancet       Date:  1979-01-20       Impact factor: 79.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.